Navigation Links
Anti-PERK, phospho (Thr980) Antibody, Unconjugated from Cell Signaling Technology

ProductsAnti-PERK, phospho (Thr980) Antibody, Unconjugated from Cell Signaling Technology
Company Cell Signaling Technology
Item Anti-PERK, phospho (Thr980) Antibody, Unconjugated
Price $600.00
Description Phospho-PERK (Thr980) Antibody
Info Cell Signaling TechnologyCell Signaling Technology
Cell Signaling Technology, Inc.
3 Trask Lane
Danvers, MA 01923
Customer Service: 978-867-2300 / 877-616-CELL (toll-free)
Fax Number: 978 867 2488
Web Site:
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Rabbit Anti-Human MLF1 Interacting Protein / PBIP1, phospho (Thr78) Polyclonal Antibody, Unconjugated from Abcam
2. Rabbit Anti-JNK1, phospho (Thr183 / Tyr185) Polyclonal Antibody, Unconjugated from GeneTex
3. Rabbit Anti-JKK / SEK1 / MKK4, phospho Antibody, Unconjugated from MBL International
4. Anti-IRS 2, phospho (Ser731) Polyclonal Antibody, Unconjugated from BioSource International (Invitrogen)
5. Rabbit Anti-Human ErbB-2, phospho (Tyr1248) Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
6. Rabbit Anti-MAPKAPK-2, phospho (Thr222) Polyclonal Antibody, Unconjugated from Calbiochem
7. Rabbit Anti-Hck, phospho (Tyr209 / Ser211) Antibody, Unconjugated from Sigma-Aldrich
8. Rabbit Anti-Lck, phospho (Tyr192) Antibody, Unconjugated from Sigma-Aldrich
9. Rabbit Anti-ErbB2, phospho (Tyr1248) Polyclonal Antibody, Unconjugated from Abcam
10. Rabbit Anti-NMDA NR2B, phospho (Tyr1336) Polyclonal Antibody, Unconjugated from Novus Biologicals
11. Goat Anti-Human Bcl-2, phospho (Thr74) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
COMING SOON: Anti-Mouse C5/C5b, Clone BB5.1. Monoclonal Antibody...
Vesicle Associated Membrane Protein (VAMP 1/2)...
synphilin-1 (V-19)...
Rabbit polyclonal to Presenilin 1, prediluted ( Abpromise for all tested applications). entrezGeneID: 5663 SwissProtID: P49768...
Biology Products:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
(Date:11/24/2015)... Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders ... Israel time, at the law offices of Goldfarb Seligman ... Floor, Tel Aviv, Israel . ... to the Board of Directors; , election of Liat ... an amendment to certain terms of options granted to our Chief Executive ...
Breaking Biology Technology: